Crossmark

The role of neoantigen in immune checkpoint blockade therapy

Crossref DOI link: https://doi.org/10.1186/s40164-018-0120-y

Published Online: 2018-11-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yi, Ming

Qin, Shuang

Zhao, Weiheng

Yu, Shengnan

Chu, Qian

Wu, Kongming
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81572608)

National Natural Science Foundation of China (81874120)

National Natural Science Foundation of China (81172422)

National Natural Science Foundation of China (81672984)

Wuhan Science and Technology Bureau (2017060201010170)
License Information

Text and Data Mining valid from 2018-11-16
More Information

Article History

Received: 20 September 2018

Accepted: 9 November 2018

First Online: 16 November 2018